Skip to Main Content

We have a new app!

Take the Access library with you wherever you go—easy access to books, videos, images, podcasts, personalized features, and more.

Download the Access App here: iOS and Android. Learn more here!



  • Medication therapy management (MTM) providers should screen for medications that are associated with an increased risk of osteoporosis and recommend bone mineral density testing to the primary provider, if appropriate.

  • Adequate calcium and vitamin D intake is essential for prevention and treatment of osteoporosis. An evaluation of dietary calcium intake will assist in determination of required calcium supplementation.

  • Calcium carbonate is the salt of choice for calcium supplementation because it has the highest percentage of elemental calcium and is the least expensive; however, calcium citrate should be considered for elderly patients with low acid production or those on acid-reducing medications.

  • MTM providers should assess for appropriate administration of bisphosphonate therapy and counsel patients on the importance of appropriate administration to reduce adverse effects and maximize efficacy of therapy.

  • Adherence is poor with bisphosphonate therapy and decreases efficacy. MTM providers should screen for nonadherence and recommend changes in pharmacotherapy or other methods to improve adherence.


Osteoporosis is associated with low bone mass and increased bone porosity, resulting in reduced bone strength and an increased risk of bone fracture.1,2 The hip, spine, wrist, and ribs are the most commonly affected bones.2 Women have a higher risk of developing osteoporosis compared to men. Primary causes of osteoporosis include menopause and osteoporosis of aging.2 Hyperthyroidism and chronic medication use (Table 30-1) are examples of secondary causes. Additional medical conditions associated with osteoporosis are listed in Table 30-2. Table 30-3 lists the risk factors for osteoporosis and osteoporotic fractures. Hip fractures result in the greatest morbidity, mortality and increased healthcare costs in older seniors.3-5

TABLE 30-1Selected Medications Associated with Increased Bone Loss and/or Fracture Risk

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.